Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma.

Eugster, Philippe J; Maurer, Jonathan; Vocat, Céline; Abid, Karim; Matter, Maurice; Wuerzner, Grégoire; Trepp, Roman; Fischli, Stefan; Henzen, Christoph; Kolb, Walter; Bilz, Stefan; Sigrist, Sarah; Beuschlein, Felix; Nölting, Svenja; Reul, Astrid; Schütze, Ina; Hubers, Scott A; Brown, Nancy J; Grouzmann, Eric (2022). Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma. Clinica chimica acta, 534, pp. 146-155. Elsevier 10.1016/j.cca.2022.07.018

1-s2.0-S0009898122012499-main.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

Neuropeptide Y (NPY1-36) is a vasoconstrictor peptide co-secreted with catecholamines by sympathetic nerves, the adrenal medulla, and neoplasms such as pheochromocytomas and paragangliomas (PPGLs). It is produced by the intracellular cleavage of proNPY and metabolized into multiple fragments with distinct biological activities. NPY immunoassays for PPGL have a diagnostic sensitivity ranging from 33-100%, depending on the antibody used. We have validated a multiplex micro-UHPLC-MS/MS assay for the specific and sensitive quantification of proNPY, NPY1-39, NPY1-37, NPY1-36, NPY2-36, NPY3-36, NPY1-35, NPY3-35, and the C-flanking peptide of NPY (CPON) (collectively termed NPYs), and determined the NPYs reference intervals and concentrations in 32 PPGL patients before, during, and after surgery. Depending on the peptide measured, NPYs were above the upper reference limit (URL) in 20% to 67% of patients, whereas plasma free metanephrine and normetanephrine, the gold standard for PPGL, were above the URL in 40% and 87% of patients, respectively. Age, sex, tachycardia, and tumor localization were not correlated with NPYs. Plasma free metanephrines performed better than NPYs in the detection of PPGL, but NPYs may be a substitute for an early diagnosis of PPGL for patients that suffer from severe kidney impairment or receiving treatments that interfere with catecholamine reuptake.

Item Type:

Journal Article (Original Article)


04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Endocrinology, Diabetology and Clinical Nutrition

UniBE Contributor:

Trepp, Roman


600 Technology > 610 Medicine & health








Pubmed Import

Date Deposited:

02 Aug 2022 11:37

Last Modified:

05 Dec 2022 16:22

Publisher DOI:


PubMed ID:


Uncontrolled Keywords:

c-flanking peptide of neuropeptide Y mass spectrometry metabolism neuropeptide Y paraganglioma pheochromocytoma proneuropeptide Y secretion




Actions (login required)

Edit item Edit item
Provide Feedback